Physician

Donald S. Cross, M.D.

According to 2025 Medicare claims, Donald Cross, M.D. (NPI: 1447256110) practices cardiology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is WACO CARDIOLOGY ASSOCIATES (NPI: 1982607735; TIN: 74-1784088) and primary practice location at 76712-4054. Cross is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Cross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,414 traditional Medicare patients, billed 8,731 HCPCS/CPT codes, and received $978,115 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 8,468 prescription claims across 1,130 beneficiaries totaling $1,120,212 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 99 claims. Open Payments data shows 48 records totaling $46,574. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,439,793 to $978,115. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $276,323 to $1,120,212. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	4,196	31,046	$1,439,793
2016	3,997	24,255	$1,229,421
2017	3,674	20,895	$1,084,669
2018	3,715	17,206	$783,036
2019	4,038	14,761	$1,064,055
2020	3,260	14,512	$955,046
2021	3,144	12,705	$907,725
2022	3,043	9,111	$862,619
2023	2,873	8,771	$897,201
2024	2,414	8,731	$978,115

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	772	6,587	$276,323
2016	815	6,761	$391,054
2017	855	7,076	$440,584
2018	906	7,263	$487,703
2019	988	7,822	$665,815
2020	1,049	8,339	$799,792
2021	1,022	7,919	$839,589
2022	1,037	7,833	$917,421
2023	1,047	8,050	$1,047,750
2024	1,130	8,468	$1,120,212

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	18	$34,922
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	99	$3,868
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	306	308	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	820	1,084	$86
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	394	468	$17
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	396	470	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	445	458	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	593	25,694	$479,294
Xarelto	Rivaroxaban	165	9,847	$172,777
Entresto	Sacubitril/Valsartan	152	5,953	$128,024
Repatha Sureclick	Evolocumab	116	4,972	$95,046
Farxiga	Dapagliflozin Propanediol	51	2,250	$39,474

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$3,427	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$43,147	Currax Pharmaceuticals LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Donald S. Cross, M.D.?

Tedicare shows public-source Medicare data for Donald S. Cross, M.D. (NPI 1447256110), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Donald S. Cross, M.D. have ACO affiliation data?

Donald S. Cross, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Donald S. Cross, M.D.?

Donald S. Cross, M.D. is linked to WACO CARDIOLOGY ASSOCIATES (billing NPI 1982607735) in the available physician profile data.

Does Donald S. Cross, M.D. have Open Payments data?

Donald S. Cross, M.D. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.